中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [112]
合肥物质科学研究院 [49]
上海生物化学与细胞... [38]
化学研究所 [14]
广州生物医药与健康... [12]
大连化学物理研究所 [12]
更多
采集方式
OAI收割 [342]
iSwitch采集 [22]
内容类型
期刊论文 [345]
学位论文 [14]
会议论文 [5]
发表日期
2023 [8]
2022 [20]
2021 [22]
2020 [17]
2019 [17]
2018 [37]
更多
学科主题
Pharmacol... [16]
Cell Biol... [14]
Biochemist... [9]
Oncology [5]
Biochemist... [3]
Biochemist... [3]
更多
筛选
浏览/检索结果:
共364条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
发表日期升序
发表日期降序
D3EGFR: a webserver for deep learning-guided drug sensitivity prediction and drug response information retrieval for EGFR mutation-driven lung cancer
期刊论文
OAI收割
BRIEFINGS IN BIOINFORMATICS, 2024, 卷号: 25, 期号: 3, 页码: 10
作者:
Shi, Yulong
;
Li, Chongwu
;
Zhang, Xinben
;
Peng, Cheng
;
Sun, Peng
  |  
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2024/05/07
lung cancer
EGFR mutation
drug sensitivity prediction
patient case database
deep learning
SIBP-03, a novel anti-HER3 antibody, exerts antitumor effects and synergizes with EGFR- and HER2-targeted drugs
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2024, 页码: 10
作者:
Li, Wen-jing
;
Xie, Cheng-ying
;
Zhu, Xi
;
Tang, Jiao
;
Wang, Lei
  |  
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2024/02/19
SIBP-03
HER3
HER3-targeted therapy
neuregulin 1
EGFR
HER2
Peptide-functionalized therapeutic nanoplatform for treatment orthotopic triple negative breast cancer and bone metastasis
期刊论文
OAI收割
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2023, 卷号: 50, 页码: 102669
作者:
Li, Daifeng
;
Ma, Shengnan
;
Xu, Denghui
;
Meng, Xiaocao
;
Lei, Ningjing
  |  
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2024/03/27
Triple-negative breast cancer
Epidermal growth factor receptor
Peptide-functionalized therapy
Peptide self-assembly
Nanoplatform
许氏平鲉滤泡胎盘发生发育及gata4的调控作用研究
学位论文
OAI收割
中国科学院海洋研究所: 中国科学院大学, 2023
作者:
赵宁
  |  
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2023/06/16
Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor
期刊论文
OAI收割
MOLECULAR PHARMACEUTICS, 2023, 卷号: 20, 期号: 2, 页码: 1394-1403
作者:
Cao, Rui
;
Li, Renda
;
Shi, Hui
;
Liu, Hongguang
;
Cheng, Zhen
  |  
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2024/03/27
NIR-II
peptide
HER2
tumor
optical imaging
Development, Validation and Application of a Bridging ELISA for Detection of Antibodies against GQ1001 in Cynomolgus Monkey Serum
期刊论文
OAI收割
MOLECULES, 2023, 卷号: 28, 期号: 4, 页码: 1684
作者:
Liu, Tingting
;
Sun, Yajun
;
Deng, Xiaojie
;
Shi, Lili
;
Chen, Wenyi
  |  
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2024/03/27
antibody-drug conjugate
immunogenicity
anti-drug antibody
bridging ELISA
Immunohistochemical HER2 Recognition and Analysis of Breast Cancer Based on Deep Learning
期刊论文
OAI收割
DIAGNOSTICS, 2023, 卷号: 13, 期号: 2, 页码: 14
作者:
Che, Yuxuan
;
Ren, Fei
;
Zhang, Xueyuan
;
Cui, Li
;
Wu, Huanwen
  |  
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2023/07/12
breast cancer
HER2
IHC
whole-slide image
deep learning
Development of a bridging ELISA for detection of antibodies against ZV0203 in cynomolgus monkey serum
期刊论文
OAI收割
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2023, 卷号: 119, 页码: 10
作者:
Liu, Tingting
;
Tong, Yongliang
;
Gao, Jinli
;
Fang, Wenjing
;
Wu, Junliang
  |  
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2023/04/10
Antibody-drug conjugate
Immunogenicity
Anti-drug antibody
Bridging ELISA
Discovery of HCD3514 as a potent EGFR inhibitor against C797S mutation in vitro and in vivo
期刊论文
OAI收割
JOURNAL OF CANCER, 2023, 卷号: 14, 期号: 1, 页码: 152-162
作者:
Lai, Mengzhen
;
Zhang, Tao
;
Chen, Hao
;
Song, Peiran
;
Tong, Linjiang
  |  
收藏
  |  
浏览/下载:111/0
  |  
提交时间:2023/04/10
fourth-generation EGFR inhibitor
EGFRC797S mutation
NSCLC
drug resistance
small molecular inhibitor
Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic EGFR mutation from a phase I
期刊论文
OAI收割
BMC MEDICINE, 2023, 卷号: 21, 期号: 1
作者:
Yuankai Shi
;
Jianying Zhou
;
Yanqiu Zhao
;
Bo Zhu
;
Liangming Zhang
  |  
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2024/05/07